HAIN up +1.11% percent right now. $HAIN High is at 109.16

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
HAIN up +1.11% percent right now. $HAIN High is at 109.16 and the Low 107.16 with current volume of 270,745.

Recent News posted below.

HAIN Hain Celestial Group Recent Headline News

Treehouse Foods (THS) Crumbles: Stock Falls by 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:43AM CST
Treehouse Foods'shares dropped 6% friday , continuing the recent trend as the stock is now up around 1.4% since Oct 17.
HAIN: 108.13 (+0.45), MKC: 72.59 (-0.17), CAG: 34.51 (-0.11), THS: 79.59 (-0.57)

The Greek Gods® Brand Introduces New Black Cherry Greek-Style Yogurt
PR Newswire - Fri Nov 07, 8:08AM CST
The Greek Gods® brand has introduced a new addition to their lineup for 24-ounce Greek-Style Yogurts. After increasing consumer requests for a Black Cherry Greek-Style Yogurt flavor, The Greek Gods® brand decided to satisfy their fans' cravings with this delicious new taste. Black Cherry is an ideal match for the creamy, rich, yet slightly tangy Greek-Style Yogurt.
HAIN: 108.13 (+0.45)

Hain Celestial Q1 Earnings Beat Estimates, Outlook Intact - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:00AM CST
The Hain Celestial Group, Inc. (HAIN) started fiscal 2015 on a strong note as the company's first quarter yielded historically high revenues and adjusted earnings.
HAIN: 108.13 (+0.45), POST: 37.41 (+0.13), MKC: 72.59 (-0.17), CAG: 34.51 (-0.11)

The Hain Celestial Group's (HAIN) CEO Irwin Simon on Q1 2015 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 12:46AM CST

HAIN: 108.13 (+0.45)

The Hain Celestial Group Inc. Earnings: 3 Key Takeaways
Jason Hall, The Motley Fool - Motley Fool - Thu Nov 06, 3:00PM CST
The Hain Celestial Group   on Thursday reported earnings for the first quarter of its 2015 fiscal year, and it was another blowout. Here are the highlights: Revenue rose 35% to $631 million. Adjusted earnings per share rose 31% to...
HAIN: 108.13 (+0.45), CMG: 648.04 (-0.99), AAPL: 108.97 (-0.04)

Hain Celestial Ascends Despite Nut Butter Recall
at Investor's Business Daily - Thu Nov 06, 9:58AM CST
Despite a voluntary recall of its nut butter, Hain Celestial (HAIN) nevertheless grew earnings and revenue over 30% during its first quarter. Earnings of the Celestial Seasonings and Rice Dream maker rose 30.8% to 68 cents a share, beating views by a...
WWAV: 35.61 (-1.32), WFM: 47.80 (+0.99), HAIN: 108.13 (+0.45), GIS: 50.69 (-0.67)

The Hain Celestial Group (HAIN) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:25AM CST

HAIN: 108.13 (+0.45)

Hain Celestial beats 1Q profit forecasts
Automated Insights - Thu Nov 06, 6:48AM CST
LAKE SUCCESS, N.Y. (AP) _ The Hain Celestial Group Inc. (HAIN) on Thursday reported net income of $18.9 million in its fiscal first quarter.
HAIN: 108.13 (+0.45)

Hain Celestial beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:36AM CST

HAIN: 108.13 (+0.45)

Hain Celestial Announces First Quarter Fiscal Year 2015 Record Net Sales and Adjusted Earnings Per Share
PR Newswire - Thu Nov 06, 6:30AM CST
The Hain Celestial Group, Inc. (NASDAQ: HAIN), a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life(TM), today reported record results for its first quarter ended September 30, 2014.
HAIN: 108.13 (+0.45)

Video: 3 Hot Food & Beverage Stocks Serving Earnings Thur.
at Investor's Business Daily - Wed Nov 05, 7:12PM CST
Hain Celestial, El Pollo Loco and Monster Beverage are three hot food and beverage companies serving up quarterly earnings on Thursday. Organic and natural foods maker Hain Celestial (HAIN) reports before the open and is seen earning 67 cents a share...
KO: 42.30 (-0.02), HAIN: 108.13 (+0.45), MNST: 106.96 (-1.43), LOCO: 36.93 (+0.33)

The Hain Celestial Group Inc. Earnings Preview: Will Competition Eat Its Lunch?
Jason Hall, The Motley Fool - Motley Fool - Wed Nov 05, 4:43PM CST
Hain owns dozens of top-selling brands. Source: Hain Celestial Group. Better-for-you and organic packaged foods company  Hain Celestial Group   has grown at a tremendous -- dare I say  Chipotle -esque   -- rate over the past few years. In August,...
HAIN: 108.13 (+0.45), CMG: 648.04 (-0.99), BNNY: 45.97 (-0.01), WMT: 79.75 (+0.98), GIS: 50.69 (-0.67)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:30PM CST

CYNI: 2.81 (unch), AAP: 143.98 (+2.13), DNOW: 27.35 (-0.65), AAON: 20.77 (-0.04), CNQ: 35.93 (-0.10), HSP: 56.01 (-0.31), CNK: 35.33 (+0.32), AMSC: 1.18 (+0.01), AES: 13.56 (+0.10), MWIV: 152.31 (-1.93), BBG: 13.16 (-0.59), HZNP: 12.97 (-0.02), KATE: 29.89 (-0.48), MITL: 9.84 (-0.09), AEE: 43.17 (-0.14), HSIC: 129.44 (+0.60), HII: 109.00 (+2.17), NAVB: 1.03 (-0.19), CECE: 14.82 (+0.60), AKRX: 35.29 (-1.30), COTY: 18.77 (+0.41), GOLD: 64.37 (-2.96), IT: 83.92 (+0.38), HNR: 3.01 (-0.16), KERX: 16.35 (-0.38), CECO: 5.53 (+0.05), HSC: 20.56 (-0.48), AMRC: 8.18 (+0.02), KLIC: 13.55 (-0.01), GEO: 40.80 (-0.60), AINV: 8.23 (-0.08), BCE: 45.47 (+0.49), AZN: 73.24 (+0.36), BCRX: 10.78 (+0.32), CPN: 24.25 (+0.01), BR: 44.93 (+0.49), FUR: 16.87 (-0.08), LIN: 23.63 (-0.09), LMIA: 12.87 (-0.25), CDW: 32.87 (+0.28), CVC: 18.55 (-0.37), AAWW: 41.31 (-0.38), GNRC: 40.57 (-0.29), MPEL: 25.16 (+0.39), DTV: 87.54 (+0.14), APA: 75.04 (-1.48), CRZO: 50.70 (-2.68), BKCC: 8.92 (+0.04), ERJ: 36.54 (-1.02), AMCX: 61.42 (-0.52), LPI: 18.58 (-0.50), HAIN: 108.13 (+0.45), FSYS: 9.04 (-0.39), GLP: 42.10 (+3.20), AOL: 44.10 (+1.42), FUN: 46.95 (-0.75), BDBD: 9.05 (+0.29)

Stocks End Mildy Mixed, But Leading Growth Names Hit Hard
at Investor's Business Daily - Wed Nov 05, 3:35PM CST
Major averages ended mixed Wednesday. The Nasdaq lagged, but not by much, weighed down by weakness in 3D printing, solar, security and online travel stocks. At the close, the Dow Jones industrial average and S&P 500 scored new closing highs, rising...
MNST: 106.96 (-1.43), CAVM: 52.92 (-0.15), TSLA: 241.61 (+1.41), SWIR: 35.85 (+1.95), SWKS: 61.04 (+1.16), AKRX: 35.31 (-1.28), NXPI: 74.42 (+0.88), HAIN: 108.13 (+0.45), SCTY: 51.87 (+0.90), QCOM: 69.88 (+0.62), AVGO: 85.68 (+0.64), PAYC: 21.85 (+0.43)

1 Stock I Would Never Sell
Motley Fool Staff - Motley Fool - Wed Nov 05, 7:12AM CST
Looking for a safe, stable company to put in your long-term portfolio? We asked three Motley Fool contributors to name one stock they would never sell. They offered up Hain Celestial Group, Procter & Gamble, and Chipotle Mexican Grill. Is one...
HAIN: 108.13 (+0.45), CMG: 648.04 (-0.99), MCD: 95.08 (-0.02), PG: 89.08 (-0.05), YUM: 73.21 (+0.35)

Will Hain Celestial (HAIN) Q1 Earnings Miss Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:55PM CST
Hain Celestial (HAIN) is scheduled to release its first-quarter fiscal 2015 results on Nov 6, 2014.
HAIN: 108.13 (+0.45), LB: 76.06 (+0.45), DIS: 89.57 (-0.43), DF: 16.34 (+1.92)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 48.81 (+1.67), MNST: 106.96 (-1.43), SWKS: 61.04 (+1.16), GMCR: 154.99 (+2.09), ILMN: 189.00 (+2.65), WSM: 66.73 (+0.85), NXPI: 74.42 (+0.88), CELG: 107.64 (+1.19), HAIN: 108.13 (+0.45), AGN: 195.00 (-1.00), CNC: 93.19 (+1.47), V: 248.75 (-3.68), CALM: 42.12 (-0.91), JAZZ: 173.42 (+2.62), ALXN: 193.67 (-0.14), LOW: 57.98 (+0.29), ULTA: 122.61 (+0.86), MA: 84.71 (-0.09), AVGO: 85.68 (+0.64), PETM: 72.48 (-0.06)

Halyard Health Debuts After Spin-Off from Kimberly-Clark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:47PM CST
Halyard Health Inc. (HYH), a global medical technology company, has begun trading on the New York Stock Exchange from Nov 3 after it was spun-off from Kimberly-Clark Corporation (KMB) on Oct 31.
HAIN: 108.13 (+0.45), UNFI: 72.25 (+0.36), MKC: 72.59 (-0.17), KMB: 113.45 (+0.21)

Estee Lauder Beats Q1 Earnings, Revenues, Lowers FY View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:31AM CST
Estee Lauder Companies Inc. (EL) posted first-quarter fiscal 2015 earnings of 80 cents per share (excluding restructuring charges) which surpassed the prior-year results by 5.3%.
HELE: 63.40 (-0.64), HAIN: 108.13 (+0.45), CAG: 34.51 (-0.11), EL: 72.64 (+0.06)

Chefs' Warehouse Slumps: CHEF Falls 13.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:38AM CST
Chefs' Warehouse saw a big move last session, as the shares fell by nearly 14% which continued the downtrend for the company
HAIN: 108.13 (+0.45), POST: 37.41 (+0.13), CAG: 34.51 (-0.11), CHEF: 15.83 (unch)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading